Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX.

Kasow, Kimberly A

Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. [electronic resource] - Clinical immunology (Orlando, Fla.) Nov 2011 - 169-76 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

1521-7035

10.1016/j.clim.2011.07.005 doi


Alemtuzumab
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Bone Marrow Transplantation
Cell Survival
Forkhead Transcription Factors--deficiency
Genetic Diseases, X-Linked--genetics
Graft Enhancement, Immunologic
Graft Survival
Humans
Immunologic Deficiency Syndromes--genetics
Infant
Interleukin-2 Receptor alpha Subunit--analysis
Lymphocyte Depletion
Male
Melphalan
Point Mutation
T-Lymphocyte Subsets--cytology
T-Lymphocytes, Regulatory--cytology
Thiotepa
Thymus Gland--immunology
Transplantation Conditioning--methods
Transplantation, Homologous
Vidarabine--analogs & derivatives